Evidence map›Paper›PMID 22649499›Full record

ArticlePloS one2012

Ontogeny of Toll-like and NOD-like receptor-mediated innate immune responses in Papua New Guinean infants.

Joanne G Lisciandro, Susan L Prescott, Marie G Nadal-Sims, Catherine J Devitt, William Pomat, Peter M Siba, Meri C Tulic, Patrick G Holt, Deborah Strickland, Anita H J van den Biggelaar

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 40 citations in OpenAlex.

  1. Trial
  2. Article
  3. Strategies for active and passive pediatric RSV immunization.Therapeutic advances in vaccines and immunotherapy · 2021
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Factors influencing innate immunity and vaccine responses in infancy.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2015
    Review
  10. Review
  11. Article
  12. Ontogeny of early life immunity.Trends in immunology · 2014
    Review
  13. Altered innate immune development in HIV-exposed uninfected infants.Journal of acquired immune deficiency syndromes (1999) · 2014
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Heterologous ("nonspecific") and sex-differential effects of vaccines: epidemiology, clinical trials, and emerging immunologic mechanisms.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2013
    Review
  19. Review
  20. Role of innate immunity in neonatal infection.American journal of perinatology · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Joanne G LisciandroTelethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia, Perth, Australia. joannel@ichr.uwa.edu.au
Susan L Prescott
Marie G Nadal-Sims
Catherine J Devitt
William Pomat
Peter M Siba
Meri C Tulic
Patrick G Holt
Deborah Strickland
Anita H J van den Biggelaar
University of Western Australia · AUPapua New Guinea Institute of Medical Research · PGThe Kids Research Institute Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Studies addressing the ontogeny of the innate immune system in early life have reported mainly on Toll-like receptor (TLR) responses in infants living in high-income countries, with little or even no information on other pattern recognition receptors or on early life innate immune responses in children living under very different environmental conditions in less-developed parts of the world. In this study, we describe whole blood innate immune responses to both Toll-like and nucleotide-binding oligomerization domain (NOD)-like receptor agonists including the widely used vaccine adjuvant 'alum' in a group of Papua New Guinean infants aged 1-3 (n = 18), 4-6 (n = 18), 7-12 (n = 21) and 13-18 (n = 10) months old. Depending on the ligands and cytokines studied, different age-related patterns were found: alum-induced IL-1β and CXCL8 responses were found to significantly decline with increasing age; inflammatory (IL-6, IL-1β, IFN-γ) responses to TLR2 and TLR3 agonists increased; and IL-10 responses remained constant or increased during infancy, while TNF-α responses either declined or remained the same. We report for the first time that whole blood innate immune responses to the vaccine adjuvant alum decrease with age in infancy; a finding that may imply that the adjuvant effect of alum in pediatric vaccines could be age-related. Our findings further suggest that patterns of innate immune development may vary between geographically diverse populations, which in line with the 'hygiene hypothesis' particularly involves persistence of innate IL-10 responses in populations experiencing higher infectious pressure.

Indexed as

Age FactorsAlum CompoundsCarrier ProteinsCells, CulturedCross-Sectional StudiesHumansImmune SystemImmunity, InnateInfantInflammasomesInterferon-gammaInterleukin-10Interleukin-1betaInterleukin-6Leukocytes, MononuclearNLR Family, Pyrin Domain-Containing 3 ProteinAlum Compoundsaluminum sulfateCarrier ProteinsIL1B protein, humanInflammasomesInterferon-gammaInterleukin-10Interleukin-1betaInterleukin-6NLR Family, Pyrin Domain-Containing 3 ProteinNLRP3 protein, humanToll-Like ReceptorsTumor Necrosis Factor-alpha

Identifiers

PMID22649499
PMCPMC3359332
OpenAlexW2072409135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.